| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6758612135829347 2.6342011247436283 0.0084335515269646 0.9932411054679594 0.24257890830236 22 Q14739,Q9UBM7,P35610,Q15125,Q16850 5 |
| Degradation pathway of sphingolipids including diseases 0.9657129619812028 2.626209547924227 0.0086341645327958 0.9940016832016312 0.24257890830236 6 P06865,P07686,P16278,P06280 4 |
| Cholesterol biosynthesis with skeletal dysplasias 0.9059655862846342 2.553542665117228 0.0106633213601698 0.9982092905136648 0.26213998343751 7 Q14739,Q15392,Q9UBM7,Q15125,Q16850 5 |
| Glycosaminoglycan degradation 0.9805593451568902 2.40706446111874 0.0160813310996426 0.9999298660064748 0.3251561717571083 5 P06865,P54802,P15586,P16278 4 |
| Nephrotic syndrome 0.7358270416285858 2.372714919876858 0.0176578868286985 0.9999727711056592 0.3251561717571083 11 Q14108,O75844,Q9BT22,P52565 4 |
| Progeriaassociated lipodystrophy 0.7472350714973007 2.2363599554397333 0.0253282020125982 0.9999997330339766 0.3251561717571083 10 O75844,O60725 2 |
| 7oxoc and 7betahc pathways 0.7793405414958046 2.208352393614026 0.0272197176517952 0.9999999151390496 0.3251561717571083 9 P61916,Q15125,Q9UBM7 3 |
| Familial partial lipodystrophy fpld 0.8176500288321717 2.1908891946315583 0.0284598118604002 0.9999999600189368 0.3251561717571083 7 O75844,O60725 2 |
| Cholesterol biosynthesis pathway 0.638549677140373 1.9218669031136564 0.0546225073102526 0.999999999999996 0.3741092932645932 12 O75845,Q16850,Q9UBM7 3 |
| Metapathway biotransformation phase i and ii 0.5685412907923014 1.9018386850302984 0.0571922471243089 0.9999999999999992 0.3741092932645932 20 Q7LGA3,P07099,Q9GZZ1,Q99735,Q16850,Q86UY6 6 |
| Sphingolipid metabolism in senescence 0.6684992412368658 1.8602872368156151 0.0628448983251968 1.0 0.3852765321878765 10 P04062,P16278,Q13510 3 |
| Endothelin pathways 0.7191883798130859 1.8498996587201593 0.0643280130970467 1.0 0.3867037676653647 8 P42892 1 |
| Drug induction of bile acid pathway 0.9758091993185714 1.768380709388027 0.0769972792993654 1.0 0.3993027183971201 2 P08183 1 |
| Oxysterols derived from cholesterol 0.7166736922041366 1.7570134675489577 0.0789155136902586 1.0 0.3995132029319826 7 Q15125,Q9UBM7 2 |
| Vitamin d receptor pathway 0.6773531924997279 1.7434392191506127 0.0812569226302337 1.0 0.3995132029319826 9 Q5VV42,Q96KA5,P08183 3 |
| Cytoplasmic ribosomal proteins 0.3875962011029473 1.695707119533031 0.0899413595619051 1.0 0.421153985250191 75 P46781,P61353,P47914,P42766,P62847,P62917,P62899,Q9Y3U8,Q07020,P18077,P61313,P84098,P62277,P62269,P62081,P46782,P62861,P62841,P62910,P40429,P46779,P46777,P83731,P62266,P62241,P36578,P39019,P05387,P18124,Q02878,P39023,P46778,P46776,P62244,P62750,P23396,P62424,P61254 38 |
| Sarscov2 and covid19 pathway 0.8955783747102466 1.674900698246419 0.0939537166147981 1.0 0.4264053292517761 4 P35610,Q8WTV0 2 |
| Selenium micronutrient network 0.5885719755052938 1.657699948515057 0.0973780442304006 1.0 0.4282186608853908 12 Q8WTV0 1 |
| Ketogenesis and ketolysis 0.6934839672703159 1.6546772474084608 0.0979899847524947 1.0 0.4282186608853908 7 P53985,O43772,P35610 3 |
| Biotin metabolism including iems 0.6593826576015346 1.5783760160066125 0.114479251783941 1.0 0.4466682944513057 8 P11498,P05165,O00763,Q96RQ3 4 |
| Sphingolipid metabolism overview 0.7595608913762306 1.5501441998351424 0.1211069093156158 1.0 0.4466682944513057 5 Q13510 1 |
| Constitutive androstane receptor pathway 0.7585336594400237 1.546009141158338 0.1221023601665836 1.0 0.4466682944513057 5 P08183 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4882180785378197 1.5270896694623608 0.12673871540124 1.0 0.4466682944513057 24 P14324,O94979,Q8WTV0,Q13085,Q16850,P37268 6 |
| Genes controlling nephrogenesis 0.6623885822251745 1.5161042135022575 0.1294930030629721 1.0 0.4466682944513057 7 Q9Y5K6,O94813 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8509464829048092 1.5075484121418554 0.1316701444871859 1.0 0.4466682944513057 4 O60725 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.9005110732538395 1.46639548673275 0.142540575183576 1.0 0.4604177543222747 2 P08195 1 |
| Sphingolipid metabolism integrated pathway 0.6782739540432365 1.4556295131251933 0.1454950648456772 1.0 0.4612139454054015 6 Q13510 1 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.6756200005617896 1.4442158267496965 0.1486782743013386 1.0 0.4612139454054015 6 Q07157,P18206,P12814,P28482 4 |
| Statin inhibition of cholesterol production 0.8335484487325686 1.4419791934635364 0.1493082433431045 1.0 0.4612139454054015 4 Q8WTV0 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.5275636296573901 1.428574886367487 0.1531264565747596 1.0 0.467250390684498 15 P18206,Q14108,Q9Y5K6,P35579,Q9Y490,O43707 6 |
| Nuclear receptors in lipid metabolism and toxicity 0.9102305065917023 1.3472463939583508 0.1779008905005441 1.0 0.4998167875967669 3 P08183 1 |
| Electron transport chain oxphos system in mitochondria 0.3906804720585883 1.322294329484963 0.1860701602805667 1.0 0.5174016503932435 44 P06576,P56385,P12235,O75964,P14406,O43676,P24539,P19404,O75947,O14949 10 |
| Proximal tubule transport 0.600169555520833 1.3040674887555188 0.192210572631901 1.0 0.5253800631624634 8 P08183 1 |
| Pyrimidine metabolism and related diseases 0.6389612120493313 1.285960209852291 0.198456948712685 1.0 0.5253800631624634 6 Q05682 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5169484470536954 1.269650986638848 0.2042089789427086 1.0 0.528053206263711 12 Q32P28,Q96AY3 2 |
| Tyrobp causal network in microglia 0.7860616342224593 1.262563046288797 0.206746255333758 1.0 0.528053206263711 4 P61916 1 |
| Oxidation by cytochrome p450 0.6294614656890039 1.2448213768756673 0.2131974165100301 1.0 0.5326118394357385 6 Q16850 1 |
| Matrix metalloproteinases 0.8364565587734392 1.2095404218218166 0.2264552914046285 1.0 0.5431244793850847 2 P35613 1 |
| Fluoropyrimidine activity 0.5036589749952296 1.19692979313988 0.2313339204982147 1.0 0.5465060505809483 12 Q99808,Q92820 2 |
| Sphingolipid pathway 0.5697086663287333 1.1617670289655655 0.2453301102239116 1.0 0.5698612796539679 8 P04062,Q13510 2 |
| Nuclear receptors metapathway 0.3731498228989054 1.148918135764378 0.2505897386593168 1.0 0.5762563041533274 43 Q16543,P11166,Q99735,O95342,Q86UP2,P08183,Q16881,Q15257,P28370,P23786,P09110,P09601,P07900 13 |
| Ccl18 signaling pathway 0.5574788154348378 1.1045979230349745 0.2693338514577812 1.0 0.5885443420744108 8 Q86UE4,Q96GC9 2 |
| Pathogenic escherichia coli infection 0.4418135897411862 1.0979392664547063 0.2722310102534357 1.0 0.5891920169891403 20 P15311,P19338,Q14247,P59998 4 |
| Ferroptosis 0.4355972184696199 1.07980267628454 0.2802300591718323 1.0 0.6022300862626538 21 Q15758,P02786,Q16881,P08195,P09601 5 |
| Homologous recombination 0.5615577505904852 1.0602893871287091 0.2890129659523703 1.0 0.6133728414097068 7 O60934 1 |
| Male infertility 0.42327276730374 1.049045650601137 0.2941571083654586 1.0 0.6220526664359161 23 P08183 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.6301093321128649 1.025200604885032 0.3052685429019164 1.0 0.6293319339066538 5 O75367,Q16527,Q15648 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.63002262201973 1.0248502568708662 0.3054338486978445 1.0 0.6293319339066538 5 P07099 1 |
| Phase i biotransformations non p450 0.8119507181662508 0.995697086025442 0.3193973463775932 1.0 0.6520568663071972 3 P38571 1 |
| Glial cell differentiation 0.7713798977853566 0.9532436204270104 0.3404666499289139 1.0 0.6781013789217514 2 P26038 1 |
| Hedgehog signaling pathway wp4249 0.606925936243863 0.9318961181071168 0.351390213976769 1.0 0.6797384467091598 5 Q9Y496 1 |
| Bile acids synthesis and enterohepatic circulation 0.6928060006818719 0.9130809694271182 0.3611999583823524 1.0 0.6812763839734406 4 O95342,P51114,P28482 3 |
| Fatty acid betaoxidation 0.4183268821769051 0.9109289644619428 0.3623328032314732 1.0 0.6812763839734406 19 O43772 1 |
| Nrf2 pathway 0.4222163884270206 0.902056365252002 0.3670269265757437 1.0 0.6812763839734406 18 P09601,Q16881,Q99735 3 |
| Vasopressinregulated water reabsorption 0.44073142673426 0.9017582890446132 0.3671852815865875 1.0 0.6812763839734406 14 Q14203,Q13561,Q13409,P17612,Q14204,Q9Y6G9,P20339,P52565,Q15907,O43237 10 |
| Pentose phosphate metabolism 0.5977208005536943 0.8951029763956768 0.3707320430414524 1.0 0.6812763839734406 5 P37837 1 |
| Tryptophan metabolism 0.4393390079253578 0.8939678145761326 0.3713391119706517 1.0 0.6812763839734406 14 P35610,Q15392 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5164183087381831 0.8572049253199179 0.3913316409429206 1.0 0.6954387595069974 7 Q9NR77 1 |
| Mitochondrial complex iii assembly 0.501617050364487 0.8452572518069531 0.397967223075284 1.0 0.7008974973564702 8 Q6DKK2,O14949 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3962710473536458 0.8074766940443165 0.4193918965666077 1.0 0.727768291100878 20 P50402,Q14739 2 |
| Complement system 0.4482920483644916 0.7552358620008968 0.4501074745395277 1.0 0.7418607050515721 10 Q99829,Q07021,P39019 3 |
| Oxidative stress response 0.5064567499638924 0.718431186449133 0.4724914633523664 1.0 0.7595911808662023 6 Q16881 1 |
| Vitamin d metabolism 0.7289157102719888 0.7110244768121047 0.4770690681421805 1.0 0.7634155984637587 3 Q9UBM7 1 |
| Gastric cancer network 2 0.4019163296307106 0.7103966012359232 0.4774582302256389 1.0 0.7634155984637587 15 Q14739 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3953346191282609 0.6328320940211211 0.5268432960537157 1.0 0.8066191853956526 13 P20042,Q14152,O15372,O75821,O75822 5 |
| Mitochondrial complex iv assembly 0.4212575605014526 0.6240637647984504 0.532585709521864 1.0 0.8073468518784371 10 P14406,P10606,P13073 3 |
| Neural crest differentiation 0.4038619392243113 0.5423458935845323 0.5875802455148964 1.0 0.8472864409923786 10 Q9NR77 1 |
| Hedgehog signaling pathway wp47 0.6514480408858535 0.5196339007260664 0.6033187650897129 1.0 0.8472864409923786 2 O00422 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.5773519200229636 0.5099587526183349 0.6100803593445971 1.0 0.8487445016334063 4 Q16543,P07900 2 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.4247964679558687 0.5060489294609397 0.6128223011793748 1.0 0.8487445016334063 8 P28482,P27361,P51148,P20339,P10398 5 |
| 1q211 copy number variation syndrome 0.4901468971463736 0.4878172931759997 0.625679261214618 1.0 0.8525421804079091 5 Q07157 1 |
| Glucuronidation 0.4450732628952434 0.4751766660139488 0.6346610572586511 1.0 0.8568650429807875 6 O95394,Q16851 2 |
| Alanine and aspartate metabolism 0.4815506892580087 0.4581638142225018 0.6468347550247926 1.0 0.8652464946278716 5 P17174 1 |
| Smc1smc3 role in dna damage cornelia de lange syndrome 0.4087571859509867 0.4404493852048176 0.6596116633915234 1.0 0.8652464946278716 8 O60934 1 |
| Ras and bradykinin pathways in covid19 0.6403458697956197 0.438261570619405 0.6611966801933797 1.0 0.8652464946278716 3 Q99829 1 |
| Dna replication 0.3139302303435092 0.4164181377577849 0.6771040584476313 1.0 0.8799369922557324 27 Q9Y2S7,P56282,P24941,Q9Y619,P33991,P49642 6 |
| Regulation of actin cytoskeleton 0.3040141218436411 0.3769022149180066 0.7062462753466991 1.0 0.8925349190651903 30 P18206,Q8N8S7,P15311,Q13177,Q9NSV4,Q9UQB8,P26038,P46940,P35241,P35580 10 |
| Dopamine metabolism 0.6037478705281005 0.3743084266459708 0.7081748634614649 1.0 0.8925349190651903 2 P21964 1 |
| Glycerophospholipid biosynthetic pathway 0.3977928384919756 0.3652673106975355 0.7149118773646745 1.0 0.8925349190651903 7 O95674 1 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6126239861428844 0.363383926926278 0.7163181068213036 1.0 0.8925349190651903 3 P28482 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3623183811874845 0.3597913284204006 0.7190031884576757 1.0 0.8925349190651903 10 P37268,P35610 2 |
| Transsulfuration pathway 0.3952516705025503 0.3560331491298631 0.7218157401807774 1.0 0.8925349190651903 7 P17174 1 |
| Cysteine and methionine catabolism 0.4088550618951039 0.3459215035848147 0.7294017076425592 1.0 0.8973724194097681 6 P17174 1 |
| Proteoglycan biosynthesis 0.6046513130741844 0.3430156756447742 0.7315866673493194 1.0 0.8973724194097681 3 Q96L58 1 |
| Atm signaling in development and disease 0.3124294553263684 0.3331333790881624 0.7390336041489747 1.0 0.902366238395034 22 Q14739,O60934 2 |
| Ovarian infertility 0.5934803000755979 0.3154184381319206 0.7524439692033806 1.0 0.9115487333144072 3 P11802 1 |
| Endochondral ossification with skeletal dysplasias 0.4265114809239641 0.2848773405559439 0.7757381166056958 1.0 0.9208026320614252 5 P50454,Q9Y496 2 |
| Endochondral ossification 0.4265114809239641 0.2848773405559439 0.7757381166056958 1.0 0.9208026320614252 5 P50454,Q9Y496 2 |
| Urea cycle and associated pathways 0.3223354245294983 0.2840897223118308 0.7763416230353686 1.0 0.9208026320614252 13 Q9Y619 1 |
| Circadian rhythm genes 0.2715555624401137 0.2707491871264026 0.7865839433202684 1.0 0.9208026320614252 43 P54802,Q9UNS1,Q13330,P36873,Q9Y2W1 5 |
| Dna irdamage and cellular response via atr 0.2714125261600182 0.2275100304447289 0.820027170556312 1.0 0.9480969901225268 35 O60934,O43324,Q9UQ84,P16104,O94782 5 |
| Mecp2 and associated rett syndrome 0.293718227107496 0.215857463514186 0.8290988546031892 1.0 0.953544491648892 19 P09543,Q9UQE7,P21359,P35637,P42345,P67809 6 |
| Glycogen synthesis and degradation 0.295730809747344 0.2068241455874309 0.8361471983877109 1.0 0.955026843228953 17 Q16851,P46020,Q04446,Q15257,P46976 5 |
| Interactome of polycomb repressive complex 2 prc2 0.3497836683487251 0.2059083472565996 0.83686250499893 1.0 0.955026843228953 7 Q9NYF8 1 |
| Glycosylation and related congenital defects 0.3376885937176476 0.1885308300715522 0.8504605499149598 1.0 0.9636726315257388 8 Q9BT22,O60762 2 |
| Wnt signaling in kidney disease 0.5144804088585917 0.1691588821366503 0.8656716709420305 1.0 0.9710005434520872 2 P61586 1 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.3074367779406939 0.1595923093117663 0.8732022376097524 1.0 0.9737042737414652 10 Q99496,O75367,P28482,P16104,Q9P0M6 5 |
| Mitochondrial fatty acid synthesis pathway 0.4413613788817506 0.1563916795305134 0.8757242952521465 1.0 0.9737042737414652 4 Q53GQ0 1 |
| Oxidative phosphorylation 0.2693348840804079 0.1435955707906129 0.8858198384060472 1.0 0.9785556390399768 25 O75964,P24539,P19404,O75947,P56385 5 |
| Nonhomologous end joining 0.3673065242880753 0.1398005571918315 0.8888175730442709 1.0 0.9785556390399768 5 Q13426 1 |
| Dna mismatch repair 0.2697954038757418 0.1139600530469201 0.9092694601341088 1.0 0.987972341582181 18 Q9Y2S7,P56282,Q9UQ84 3 |
| Glutathione metabolism 0.3207096554077092 0.1041482351109726 0.9170517128741582 1.0 0.9941351367268796 6 O75874,P00390,P48507,P11413,P48506 5 |
| Caloric restriction and aging 0.4751917350188627 0.100438450283026 0.9199962451743666 1.0 0.9941351367268796 3 P43490 1 |
| Atm signaling pathway 0.2638781104953792 0.0846006649807834 0.9325788703869388 1.0 1.0 14 P16104,O60934 2 |
| Leptin and adiponectin 0.4428478034143855 0.0672884484991957 0.9463520728091316 1.0 1.0 3 Q13085 1 |
| Pparalpha pathway 0.2906368254365974 0.0631487565439148 0.9496480496362768 1.0 1.0 7 P50416,P23786,P06493,P09110 4 |
| Exerciseinduced circadian regulation 0.2545609566474268 0.0598794163382361 0.9522516738554364 1.0 1.0 14 Q00577,Q16851 2 |
| Pentose phosphate pathway in senescent cells 0.3160606049050447 0.0558723788405711 0.955443474939014 1.0 1.0 5 P37837 1 |
| G1 to s cell cycle control 0.2468723442307965 0.0476022528791558 0.962033236528996 1.0 1.0 23 Q9Y619,P56282,P49642 3 |
| Type ii diabetes mellitus 0.3860525593631368 0.0316114179556442 0.974781937729582 1.0 1.0 3 P42345 1 |
| Transcription cofactors ski and skil protein partners 0.2916098226466548 0.0293654804843918 0.9765731035075726 1.0 1.0 5 Q96ST3,P51608,O14744,P21359 4 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.3228775997272397 0.0209682777139918 0.9832709608267624 1.0 1.0 4 P42345,Q01581,P49327 3 |
| Hair follicle development organogenesis part 2 of 3 0.311179277436938 0.0140921081414082 0.9887564966225976 1.0 1.0 3 P35222,P05556 2 |
| Striated muscle contraction pathway 0.2986703034435699 0.0106152027493157 0.9915304526784968 1.0 1.0 4 P67936,P06753,O43707 3 |
| Ciliary landscape 0.2149336043167693 0.0024181745118856 0.9980705777720442 1.0 1.0 99 P16278,A0AVF1,Q7L5Y9,Q9H7D7,Q9Y312,Q9Y266,Q9C0C2,O95400,P52565,Q9H4A3,Q96A65,P61006,P10619,P33991,P46940,P06280 16 |
|
|
